ReviewRedox biology2026
Piezo1: Molecular mechanisms and therapeutic potential in ligamentum flavum hypertrophy and lumbar spinal stenosis.
Review in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ligamentum flavum hypertrophy (LFH) is a major cause of lumbar spinal stenosis, which can lead to progressive lower back pain and impaired nerve function, resulting in a significant global disease burden. At present, the pathological mechanism of LFH has not been fully elucidated, and effective treatment methods are lacking. Piezo1 is a channel activated by mechanical stress. It is activated under mechanical stress and participates in various physiological and pathological processes related to oxidative stress, including inflammation, fibrosis, ferroptosis, vascular remodeling and pyrolysis. However, its role in the development of LFH is still unclear. In this review, we examined the role of Piezo1 in oxidative stress, inflammation, fibrosis, ferroptosis, vascular remodeling, cell pyroptosis, as well as its potential connection with LFH. These findings provide new ideas for the treatment of the LFH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.